Cancer and Metastasis Reviews

, Volume 22, Issue 4, pp 375–384 | Cite as

The role of integrin-linked kinase (ILK) in cancer progression

  • Sujata Persad
  • Shoukat Dedhar


Integrin-linked kinase (ILK) is an intracellular protein, which interacts with the cytoplasmic domains of integrin beta1 and beta3 subunits. ILK is a 59 kDa protein containing a phosphoinositide phospholipid-binding domain flanked by an N-terminal ankyrin repeat domain and a C-terminal serine/threonine protein kinase domain. Genetic and biochemical evidence have established an essential role of ILK in connecting integrins to the actin cytoskeleton. Apart from integrins, ILK interacts with several adaptor and signaling proteins resulting in its activation and localization to focal adhesion plaques. The kinase activity of ILK is stimulated upon integrin engagement, as well as by growth factors and chemokines in a PI-3Kinase-dependent manner. ILK can mediate the phosphorylation of a variety of intracellular substrates, most notable of which are: protein kinase B (PKB/Akt), glycogen synthase kinase-3 (GSK-3) and myosin light chain. Gain and loss of function strategies have shown that overexpression, and/or constitutive activation of ILK results in oncogenic transformation and progression to invasive and metastatic phenotypes. In addition ILK expression and activity are upregulated in several types of cancers. In this review, we summarize the adaptor and signaling properties of ILK, and also progress in the identification of therapeutic strategies for inhibition of ILK activity.

integrins PKB/Akt cell survival tumorigenesis EMT therapeutics 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S: Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379: 91–96, 1996Google Scholar
  2. 2.
    Li F, Liu J, Mayne R, Wu C: Identification and characterization of a mouse protein kinase that is highly homologous to human integrin-linked kinase. Biochim Biophys Acta 1358: 215–220, 1997Google Scholar
  3. 3.
    Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S: Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/ AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211–11216, 1998Google Scholar
  4. 4.
    Tu Y, Li F, Goicoechea S, Wu C: The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol 19: 2425–2434, 1999Google Scholar
  5. 5.
    Huang Y, Wu C: Integrin-linked kinase and associated proteins (review). Int J Mol Med 3: 563–572, 1999Google Scholar
  6. 6.
    Dedhar S: Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol 12: 250–256, 2000Google Scholar
  7. 7.
    Tu Y, Li F, Wu C: Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIMonly protein PINCH and components of growth factor receptor kinase-signaling pathways. Mol Biol Cell 9: 3367–3382, 1998Google Scholar
  8. 8.
    Li F, Zhang Y, Wu C: Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats J Cell Sci 112: 4589–459, 1999Google Scholar
  9. 9.
    Hannigan GE, Bayani J, Weksberg R, Beatty B, Pandita A, Dedhar S, Squire J: Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15.5-p15.4. Genomics 42: 177–179, 1997Google Scholar
  10. 10.
    Tu Y, Huang Y, Zhang Y, Hua Y, Wu C: A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153: 585–598, 2001Google Scholar
  11. 11.
    Yamaji S, Suzuki A, Sugiyama Y, Koide Y, Yoshida M, Kanamori H, Mohri H, Ohno S, Ishigatsubo Y: A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol 153: 1251–1264, 2001Google Scholar
  12. 12.
    Nikolopoulos SN, Turner CE: Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J Biol Chem 276: 23499–23505, 2001Google Scholar
  13. 13.
    Guo L, Wu C: Regulation of fibronectin matrix deposition and cell proliferation by the PINCH-ILK-CH-ILKBP complex. FASEB J 16: 1298–1300, 2002Google Scholar
  14. 14.
    Leung-Hagesteijn C, Mahendra A, Naruszewicz I, Hannigan: Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrinlinked kinase, ILK1. EMBO J 20: 2160–2170, 2001Google Scholar
  15. 15.
    Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar: Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97: 3207–1322, 2000Google Scholar
  16. 16.
    Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S: Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276: 27462–27469, 2001Google Scholar
  17. 17.
    Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S: Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 153: 1161–1174, 2001Google Scholar
  18. 18.
    Carter N, Nakamoto T, Hirai H, Hunter T: EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat Cell Biol 4: 565–573, 2002Google Scholar
  19. 19.
    Dedhar S, Williams B, Hannigan G: Integrin-linked kinase (ILK): A regulator of integrin and growth-factor signaling. Trends Cell Biol 9: 319–323, 1999Google Scholar
  20. 20.
    Morimoto AM, Tomlinson MG, Nakatani K, Bolen JB, Roth RA, Herbst R: The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity. Oncogene 19: 200–209, 2000Google Scholar
  21. 21.
    Lynch DK, Ellis CA, Edwards PA, Hiles ID: Integrinlinked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18: 8024–8032, 1999Google Scholar
  22. 22.
    Zervas CG, Gregory SL, Brown NH: Drosophila integrinlinked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol 52: 1007–1018, 2001Google Scholar
  23. 23.
    Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD: C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 12: 787–797, 2002Google Scholar
  24. 24.
    Zervas CG, Brown NH: Integrin adhesion: When is a kinase a kinase? Curr Biol 12(10): R350-R351, 2002Google Scholar
  25. 25.
    Deng JT, Van Lierop JE, Sutherland C, Walsh MP: Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase. J Biol Chem 276: 16365–16373, 2001Google Scholar
  26. 26.
    Wang XQ, Sun P, Paller AS: Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor. J Biol Chem 2002Google Scholar
  27. 27.
    Wu C, Dedhar S: Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155: 505–510, 2001Google Scholar
  28. 28.
    Troussard AA, Tan C, Yoganathan TN, Dedhar S: Cellextracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase-and glycogen synthase kinase 3-dependent manner. Mol Cell Biol 19: 7420–7427, 1999Google Scholar
  29. 29.
    D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG: The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 32649–32657, 2000Google Scholar
  30. 30.
    Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S: The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19: 5444–5452, 2000Google Scholar
  31. 31.
    Attwell S, Roskelley C, Dedhar S: The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19: 3811–3815, 2000Google Scholar
  32. 32.
    Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J, Dedhar S: Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 272: 13937–13944, 1997Google Scholar
  33. 33.
    Janji B, Melchior C, Vallar L, Kieffer N: Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation. Oncogene 19: 3069–3077, 2000Google Scholar
  34. 34.
    Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S, McDonald JA, Dedhar S: Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273: 528–536, 1998Google Scholar
  35. 35.
    Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S: Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/-human colon carcinoma cells. Oncogene 20: 133–140, 2001Google Scholar
  36. 36.
    Marotta A, Tan C, Gray V, Malik S, Gallinger S, Sanghera J, Dupuis B, Owen D, Dedhar S, Salh B: Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene 20: 6250–6257, 2001Google Scholar
  37. 37.
    Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH: Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 7: 1987–1991, 2001Google Scholar
  38. 38.
    Chung DH, Lee JI, Kook MC, Kim JR, Kim SH, Choi EY, Park SH, Song HG: ILK (beta1-integrin-linked protein kinase): A novel immunohistochemical marker for Ewing's sarcoma and primitive neuroectodermal tumor. Virchows Arch 433: 113–117, 1998Google Scholar
  39. 39.
    White DE, Cardiff RD, Dedhar S, Muller WJ: Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20: 7064–7072, 2001Google Scholar
  40. 40.
    Somasiri A, Howarth A, Goswami D, Dedhar S, Roskelley CD: Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci 114: 1125–1136, 2001Google Scholar
  41. 41.
    Sternlicht MD, Bissell MJ, Werb Z: The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19: 1102–1113, 2000Google Scholar
  42. 42.
    Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ: Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21: 2203–2212, 2001Google Scholar
  43. 43.
    Yamada KM, Araki M: Tumor suppressor PTEN: Modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 114: 2375–2382, 2001Google Scholar
  44. 44.
    Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL: Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95: 5246–5250, 1998Google Scholar
  45. 45.
    Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183–4186, 1997Google Scholar
  46. 46.
    Wang SC, Makino K, Xia W, Kim JS, Im SA, Peng H, Mok SC, Singletary SE, Hung MC: DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene 20: 6960–6964, 2001Google Scholar
  47. 47.
    Takada T, Noguchi T, Inagaki K, Hosooka T, Fukunaga K, Yamao T, Ogawa W, Matozaki T, Kasuga M: Induction of apoptosis by stomach cancer-associated protein-tyrosine phosphatase-1 (SAP-1). J Biol Chem 277: 34359–34366, 2002.Google Scholar
  48. 48.
    Nollet F, Berx G, van Roy F: The role of the E-cadherin/ catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 2: 77–85, 1999Google Scholar
  49. 49.
    Berx G, Van Roy F: The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 3: 289–293, 2001Google Scholar
  50. 50.
    Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AG, Baulida J: Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 277: 39209–39216, 2002Google Scholar
  51. 51.
    Kiss E, Muranyi A, Csortos C, Gergely P, Ito M, Hartshorne DJ, Erdodi F: Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton. Biochem J 365: 79–87, 2002Google Scholar
  52. 52.
    Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP: Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J 367: 517–524, 2002Google Scholar
  53. 53.
    Tan C, Mui A, Dedhar S: The integrin linked kinase (ILK) regulates inducible nitric oxide synthase (iNOS) and Cyclooxygenase-2(COX-2) expression in an NFkB dependent manner J Biol Chem 277: 3109–3116, 2002Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  1. 1.Hamilton Regional Cancer Center and McMaster UniversityHamiltonCanada
  2. 2.BC Cancer Agency and Department of BiochemistryUniversity of British ColumbiaVancouverCanada

Personalised recommendations